The results of previous epidemiologic research on the possible association between maternal smoking during pregnancy and risk of oral clefts in offspring have been inconsistent. This may be due in part to methodological limitations, including imprecise measurement of tobacco use, failure to consider etiologic heterogeneity among types of oral clefts, and confounding. This analysis, based on a large case-control study, further evaluated the effect of first trimester maternal smoking on oral facial cleft risk by examining the dose-response relationship according to specific deft type and according to whether or not additional malformations were present. A number of factors, including dietary and supplemental folate intake and family history of clefts, were evaluated as potential confounders and effect modifiers. Data on 3,774 mothers interviewed between 1976 and 1992 by the Slone Epidemiology Unit Birth Defects Study were used. Study subjects were actively ascertained from sites in areas around Boston, Massachusetts and Philadelphia, Pennsylvania; the state of Iowa; and southeastern Ontario, Canada. Cases were infants with isolated defects-cleft lip alone (n = 334), cleft lip and palate (n = 494), or cleft palate alone (n = 244)-and infants with clefts plus (+) additional malformations: cleft lip+ (n = 58), cleft lip and palate+ (n = 140), or cleft palate-i-(n = 209). Controls were infants with defects other than clefts, excluding defects possibly associated with maternal cigarette use. There were no associations with maternal smoking for any oral cleft group, except for a positive dose response among infants with cleft lip and palate+ (for light smokers, odds ratio (OR) = 1.09 (95% confidence interval (Cl): 0.6,1.9); for moderate smokers, OR = 1.84 (95% Cl: 1.2, 2.9); and for heavy smokers, OR = 1.85 (95% Cl: 1.0, 3.5), relative to nonsmokers). This finding may be related to the additional malformations rather than to the cleft itself. Am J Epidemiol 1999; 150:683-94.
Oral cleft defects, specifically cleft lip and cleft palate, are among the most prevalent congenital malformations worldwide (1) . Prevalence rates for all types of clefts are approximately 1 in every 800 live births, although the incidence among all conceptions may be much higher (2) . Several potential risk factors have been studied, including parental age, maternal seizure disorders, vitamin deficiency, and phenytoin or diazepam use during pregnancy, but findings have been inconclusive (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . The relation between maternal tobacco use and oral cleft risk has been studied more extensively (3) (4) (5) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) , but these findings have been inconclusive as well. Discrepancies in results may be the consequence of methodological limitations such as small sample size, inclusion of diverse cleft types within a single case group, inclusion of infants with syndromes or additional malformations, or lack accurate information on smoking, particularly on the timing of smoking during gestation. The purpose of this study was to further investigate the relation between maternal smoking and risk of oral clefts using data from a large case-control study of birth defects that included multiple oral cleft case groups and detailed information on smoking history.
MATERIALS AND METHODS
The Slone Epidemiology Unit Birth Defects Study was initiated in 1976 at Boston University and is an ongoing multicenter epidemiologic program using case-surveillance techniques to study birth defects in relation to environmental exposures (32) . Werler et al. (23) used Birth Defects Study data from [1983] [1984] [1985] [1986] [1987] to assess the relation between smoking and clefts. The present analysis expands on that effort, partly by uti-lizing data collected between 1978 and 1992. Study subjects (liveborn and stillborn infants and elective terminations) were actively ascertained from over 80 institutions in the greater metropolitan areas of Boston, Massachusetts; Philadelphia, Pennsylvania; southeastern Ontario, Canada; and, for 1983-1985, five counties in the state of Iowa. Subjects from these areas are identified through weekly contact with newborn nurseries and through routine review of admission and discharge lists, hospital discharge diagnoses, and clinical and surgical logs at tertiary care hospitals and specialty clinics. Once infants are identified, their physicians are asked for confirmation of the malformation diagnoses and permission to contact the mothers. Mothers who agree to participate are interviewed in their homes (or occasionally by telephone) by a nurse interviewer within 6 months following delivery. The interview has remained fairly constant over the 15-year study period. It collects information on maternal and paternal demographic factors and health behaviors, family history of birth defects, maternal reproductive and medical history, maternal exposure to vitamins and medications, and maternal smoking. In 1988, more detailed questions were added concerning maternal tobacco and alcohol use, and a dietary history was added. Therefore, we conducted two separate analyses: one (analysis 1) for the entire study period (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) and a second (analysis 2) for the last 5 years only (1988) (1989) (1990) (1991) (1992) , when more specific data on maternal smoking and other factors became available.
Study population
Since 95 percent of the study subjects were White and the Nonwhite subjects were too few to allow for stable statistical comparisons, the analysis was restricted to Whites. Pregnancies ending in elective termination were not included, since they were not ascertained throughout the entire study and the timing of those interviews differed from that of the women with full term pregnancies.
Case group definition. Cases were liveborn or stillborn infants assigned an International Classification of Diseases, Ninth Revision (ICD-9) (33) diagnosis of 749.1 (cleft lip), 749.2 (cleft Up and palate), or 749.0 (cleft palate). Infants with clefts of known origin (amniotic bands, fetal alcohol syndrome, Mendelian inherited disorders, or chromosomal anomalies) were excluded, as were those with a diagnosis of cleft uvula or submucous cleft only. Based on differences in the timing of embryologic development, as well as differences in recurrence risk, cleft lip (CL), cleft lip with cleft palate (CLP), and cleft palate only (CP) were considered as distinct outcome categories. However, the CL and CLP groups were also combined (cleft lip with or without cleft palate (CL/P)) to allow for comparison with previous studies. To further reduce possible etiologic heterogeneity, we divided each of these case groups again according to whether or not additional noncleft malformations were present. Infants with an ICD-9 congenital malformation diagnosis in addition to a 749 code were considered to have other anomalies. The notation shown in table 1 was used to differentiate among the eight case groups. The distribution of case group infants by cleft category, ICD-9 diagnostic classification status, and analysis period is presented in table 2.
Control group definition. Controls were selected from livebom or stillborn infants assigned malformation codes other than 749 (oral cleft). To decrease potential selection bias, we excluded infants with anomalies reported to be associated with smoking. These categories include central nervous system defects, cardiovascular and musculoskeletal defects, inguinal hernia, and pyloric stenosis (2, 9, 17, 18, 21, 24, 25, 34) . In addition, infants with syndromes associated with oral clefts (e.g., trisomy 13), despite the absence of a cleft, were excluded. Digestive, genital, and urinary system anomalies comprised the largest malformation groups among infants included as controls. The distribution of controls by malformation category, smoking status, and analysis period is presented in table 3. Analysis 1 (1976 Analysis 1 ( -1992 . For analysis 1, efforts were made to define smoking and the number of cigarettes smoked per day as consistently as possible across differing data collection formats. Never smokers and those who had stopped smoking prior to conception were considered nonsmokers. Only women who reported smoking during pregnancy were defined as smokers. Women whose smoking status during the first 13 weeks of pregnancy was uncertain were excluded. For data from 1978-1982, dose was defined as the peak number of cigarettes smoked per day; for 1983-1987, it was the peak number smoked per day after a woman knew she was pregnant; and for 1988-1992, it was the peak number smoked per day after a woman first thought she was pregnant.
Exposure assessment
Variables examined as potentially confounding factors or effect modifiers included infant sex; parental age and education; maternal history of or treatment for convulsive disorder; ectopic pregnancy, miscarriage, therapeutic abortion, or stillbirth; and family history of oral clefts among first degree relatives. Analysis 2 (1988 Analysis 2 ( -1992 . For interviews conducted between 1988 and 1992, the availability of information on dose and timing of exposure made it possible to define smoking status with greater precision. Therefore, in analysis 2 the exposure interval was defined as the first 84 days (12 weeks) following the last menstrual period, to reflect the embryologic phase of palatal closure. Women who had never smoked or had stopped smoking prior to their last menstrual period were considered nonsmokers. Only women who reported smoking during pregnancy were defined as smokers. For those who did not change the amount they smoked during pregnancy or changed the amount after the exposure interval, dose was defined as the daily number of cigarettes smoked prior to the last menstrual period. For women who changed the daily number of cigarettes smoked during the first 84 days, dose was the weighted mean number of cigarettes smoked per day based on how many days the woman had smoked at each level.
In addition to the variables included in analysis 1, analysis 2 considered maternal intake of dietary and supplemental folate, whether the pregnancy had been planned, and annual family income as potentially confounding factors or effect modifiers.
Analytic strategy
Light smoking was defined as 1-14 cigarettes per day, moderate smoking as 15-24 cigarettes per day, and heavy smoking as >24 cigarettes per day. Stratified analyses were used to evaluate risk factors for their potential effect modification or confounding of the relation between maternal cigarette smoking and oral cleft risk. Mantel-Haenszel odds ratios with testbased 95 percent confidence intervals were estimated, adjusting for each factor. Covariates for which adjusted odds ratios differed by more than 10 percent from the crude estimate were considered potential confounders of the smoking-oral cleft relation. Covariates for which stratum-specific odd ratios resulted in a test of homogeneity with p values of <0.15 were examined as effect modifiers. Unconditional logistic regression methods were used to derive the odds ratio as an estimate of relative risk, controlling for the confounding factors identified by the stratified analyses (35) . Variables representing study period and geographic area were retained in each regression model to control for the effects of secular trends and regional variation in smoking behaviors and subject ascertainment. Effect modification was evaluated using interaction terms including the smoking variable and the covariate of interest.
RESULTS

Analysis 1
Data on subject participation became available in 1983, at which time participation was 84 percent among cases and 77 percent among controls. Of 1,794 potential cases, 315 were excluded because of clefts of known etiology (n = 105), cleft uvula (n = 6), Nonwhite or unknown race (n = 100), uncertain or missing data on smoking {n = 97), or elective termination (n = 7); this resulted in 1,479 subjects. Among 2,869 potential controls, exclusion of therapeutic abortions (n = 204), infants of Nonwhite or unknown race (n = 227), and infants whose mothers' smoking status was missing or uncertain (n = 143) resulted in a total of 2,295 controls.
The distribution of demographic and reproductive factors by case group and among controls is presented in table 4. The distribution of subjects by study area was consistent for the case and control groups. Infants with CL and CLP with or without associated malformations were more often male, while infants with CP were more often female. Nearly three fourths of controls were male, because of the large number of infants with hypospadias in this group. Parents of infants with isolated clefts were slightly younger and less educated than parents of cases with multiple malformations or parents of controls. Between 3 percent and 9 percent of case group mothers reported a positive family history of oral clefts among first or second degree relatives, as compared with 0.3 percent of controls. Slightly more mothers of infants with CL or CL/P reported a history of convulsive disorders compared with controls. A somewhat higher proportion of mothers of infants with CL or CLP+ reported a history of miscarriage compared with mothers of cases in other groups or mothers of controls. More mothers of infants with CL+ and CL/P+ reported a previous therapeutic abortion compared with mothers of infants with isolated clefts or control group mothers. Maternal use of folate supplements during the first trimester ranged from 6 percent among mothers of infants with CL to 22 percent among mothers of infants with CL+. Folate supplement use was report by 15 percent of control mothers.
The mean numbers of days between birth and interview were comparable for cases (134 days, standard deviation 40) and controls (139 days, standard deviation 32); 4 percent of both case and control mothers were interviewed at sites other than their home, and mean gestational age was 39 weeks for both cases and controls. Less than 1 percent of case and control mothers reported the use of benzodiazepines (data not shown).
Crude and adjusted odds ratios for cigarette smoking from analysis 1 are presented in favor of the larger CLP category. A slight inverse doseresponse gradient was found for CUP, and a positive dose response was found for infants with CL/P+. History of previous miscarriage remained an effect modifier for this group.
Analysis 2
There were 304 oral cleft cases and 600 malformed controls from the last 5 years of the study (table 6) . The more precise definition of exposure increased the proportion of smokers in this population from 28 percent to 32 percent for cases and from 26 percent to 27 percent for controls. There were too few exposed cases to examine amount of smoking. For any smoking, the findings in analyses 1 and 2 were similar for infants in the CL, CLP, CL+, and CP+ groups (tables 4 and 5). Increased risk estimates were observed for CP and CLP+ in analysis 2, but the latter finding was attributed to smoking-associated defects, as in analysis 1.
DISCUSSION
The results of this study suggest that maternal smoking during pregnancy is not associated with a meaningful increase in risk for most oral cleft categories. There was a modest increase in risk for CLP when it was accompanied by additional malformations, which may be due to the presence of anomalies associated with smoking. Table 7 presents an overview of results from several studies using all smokers and nonsmokers. The studies by Khoury et al. (27) and Werler et al. (23) used infants with malformations as controls. We found no association between maternal smoking and risk for CL/P in either analysis, which is similar to findings reported by Shiono et al. (22) and Kallen (31) . (Werler et al. (23) also found no association, but those data are included as part of the present study.) Kallen's (31) recent report of a positive association for CL/P+ (odds ratio (OR) = 1.43; 95 percent Cl: 0.98, 2.09) was very similar to ours. Several other investigators reported a positive association for CL/P (25, 27, 28) but no association for CL/P+, which is opposite our findings. Finally, although combining the CL and CLP groups allowed for comparison with other studies, it is important to note that the magnitude of the observed effect was determined by the larger of the two groups, CLP. percent CI: 1.1,4.5), but several other studies found no association (4, (22) (23) (24) 29) , and neither did our analysis 1. The lack of an association of smoking with CP+ in our study is consistent with other reports in the literature (4, 23, 25, 28, 30, 31) , with the exception of an increased risk (OR = 4.1; 95 percent CI: 0.99, 16.9) reported by Khoury et al. (27) , which was based on a total of only nine cases.
Am J Epidemiol Vol. 150, No. 7, 1999 The discrepancies among previous studies, as well as between some previous findings and this investigation, do not provide a clear answer concerning the role of maternal smoking during pregnancy in oral cleft risk. As explanations for recurring weak and inconsistent associations in studies of human teratogens, Khoury et al. (36) suggest consideration of unmeasured confounding, exposure misclassification, etdologic heterogeneity in defining outcomes, biologic interactions, and differential prenatal survival. Indeed, many previous studies have not adequately addressed the influence of potential confounders such as family history of oral clefts, maternal medical conditions, or prescription drug use (3, (17) (18) (19) 22, 24, 25) . While bias due to unknown confounders is always possible, this study examined the effect of numerous demographic, medical, and lifestyle factors and was (to our knowledge) the first analysis of maternal smoking and oral clefts to also examine the effects of family history, maternal convulsive disorder, exposure to anticonvulsant medications, and supplementary folic acid. In addition, geographic and secular variation was controlled. With few exceptions, confounding was not present in these data, raising the question of whether confounding accounts for the differing results observed across studies.
Differences in assessment and timing of exposure, as well as misclassification of maternal smoking, may add to the inconsistent results and weak associations. In previous studies, data on smoking were obtained through telephone or personal interviews or through review of medical records or vital records. Maternal smoking was variously defined as smoking at any time during pregnancy, smoking prior to conception and/or during pregnancy, or smoking during the first trimester of pregnancy only. In our investigation, interview data rather than vital record data were used, and very specific questions were used to obtain more detailed information than could be provided by more general, open-ended questions. Subjects with questionable smoking histories were excluded. Furthermore, the specific timing of exposure was narrowly defined to be consistent with the embryologically appropriate period, especially in analysis 2. To examine whether or not improvement in exposure assessment affected study results, we compared the prevalence of smoking for subjects interviewed during the last 5 years of the study using the two definitions of exposure (analysis 1 vs. analysis 2). For all but one case group (CL+), the more precise definition reflected an increase in the proportion of smokers. While the relative risk for CP increased from 1.1 in analysis 1 to 2.1 in analysis 2, use of more precise exposure information generally made little difference. Although data from analysis 2 were also part of analysis 1, they made up the minority of the overall data.
The earliest studies considered all clefts as a single category (3, 5, (17) (18) (19) (20) . More recently, CP has been viewed apart from CUP, and infants with multiple malformations or syndromes have been considered separately as well (22, 23, 25, 27, 28) . Our analysis of 1,479 infants with oral clefts represents one of the largest samples to date, permitting us to separate clefts into more embryologically and epidemiologically distinct categories while maintaining adequate statistical power. The differences in risk observed between the CL and CLP groups and the CL+ and CLP+ groups indicate that such distinctions may be of value. Interestingly, we observed different effects for the CL and CLP groups. Specifically, our results suggested a positive dose-response gradient for CLP+ and no increase in risk for CL or CL+; however, previous studies did not include these categories, which limits their interpretation.
The inverse dose-response gradient present for the CLP-smoking relation in this study and present among mothers of infants with CP (28) and CL/P and CP+ (23) in other reports is difficult to explain. While it is possible that this effect is the result of systematic underreporting of smoking level by case mothers (the inverse relation is less striking but persists in analysis 2), it is more likely that a variety of factors contributed to this effect. This decrease may also be due in part to differential prenatal survival and/or biologic interactions (36) . To explore this possibility, we reviewed the history of miscarriage by level of smoking among study mothers. As smoking level increased, the proportion of women who reported a previous miscarriage increased for both cases and controls, although the increase was greater among cases (13 percent for light smokers, 33 percent for heavy smokers) than among controls (16 percent for light smokers, 24 percent for heavy smokers). This reproductive history is consistent with the increased risk of spontaneous abortion reported among smokers (21, (37) (38) (39) (40) , as well as the higher prevalence of oral clefts observed in studies of human embryos and fetuses, compared with liveborn infants only (41, 42) . It may be that women who are heavy smokers are more likely to miscarry a fetus with an oral cleft and therefore appear less often in study samples (43) . While these data did not directly measure whether heavy smokers are more likely to experience the loss of a fetus with a cleft, an overall higher proportion of miscarriages among smokers suggests this as a possible explanation for the higher risk observed in the lightest smokers. However, such an effect would have to be specific to clefts (rather than malformations overall), since this study used infants with other malformations as controls.
There has been a great deal of discussion concerning the suitability of using infants with other malformations as controls in birth defects research (44) (45) (46) (47) (48) . We believe that our exclusion of all malformations possibly associated with maternal smoking, as well as the size and heterogeneous nature of the control group chosen, decreased the probability of selection bias. On the other hand, mothers in this restricted control group (infants with other malformations) most likely reported smoking behavior with similar accuracy as mothers of infants with clefts, thereby minimizing bias due to differential recall and reporting. Any remaining selection bias would likely be nondifferential and would create a slight underestimate of effect, if anything. However, as noted above, when the criteria used in control group selection were applied to the CLP+ cases (by excluding infants with additional malformations associated with smoking), the positive association was no longer present in this group.
A potential limitation of the present study is the possibility of selection bias due to incomplete ascertainment of infants with oral clefts related to smoking status. We believe that the data are representative of infants with oral clefts (8, (49) (50) (51) and mat this type of selection bias is unlikely, because the large majority of study subjects were identified through tertiary care centers, and infants with clefts need such care independent of maternal smoking.
The present study was limited in its generalizability because of the exclusion of Nonwhite subjects. Although this exclusion did not substantially decrease the sample size and eliminated one possible bias, it would be interesting to examine the effect of smoking among women in different racial and ethnic groups, particularly those with a relatively higher prevalence of oral clefts, such as Asians and Native Americans (52) .
It is likely that the effect of maternal smoking on cleft risk depends on specific biologic interactions between smoking and genetic (and possibly environmental) factors. While the view that both factors play a role in the etiology of clefts has long been suggested (53) (54) (55) (56) (57) , only recently have studies identified specific components of a gene-environment interaction that increase an infant's risk for oral clefts (29, 30) . Studies by Hwang et al. (29) and Shaw et al. (30) have provided preliminary evidence suggestive of a geneenvironment interaction between maternal smoking and the transforming growth factor-a Taql polymorphism in the etiology of these defects. The background distribution of the polymorphism varies for cleft types between these two studies (29, 30) (as well as among others), suggesting that their findings may not be generalizable to other data sets, including ours. However, evaluation of maternal smoking during pregnancy within subgroups with known genetic susceptibilities may be warranted.
The results of this study have added to the inconsistent findings from other studies regarding the role of smoking in relation to various types of clefts. No meaningful associations were present for cleft groups other than CLP in the presence of additional malformations, a finding which may have been due to the malformations themselves. Despite the lack of an association, differences in the specific covariates included in the regression models and in the dose-response effects support the importance of continued differentiation among these groups in the future. While the issue of a general effect of smoking remains unclear, other approaches are increasingly suggestive that smoking may exert an effect in subpopulations with selected genetic susceptibilities.
